Patents

US 8119163 B2: Nanoparticulate and controlled release compositions comprising cefditoren

Granted
2012-02-21
Filed
2007-02-05 application 11671276
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention provides a composition comprising a cefditoren, or a salt, derivative, prodrug, or other form thereof, for example, cefditoren pivoxil, useful in the treatment and prevention of infections and related conditions. The invention provides a composition which comprises nanoparticulate particles comprising the cefditoren, or a salt, derivative, prodrug, or other form thereof and at least one surface stabilizer. The nanoparticulate particles have an effective average particle size of less than about 2000 nm. The invention provides also a composition that delivers a cefditoren, or a salt, derivative, prodrug, or other form thereof, or nanoparticles comprising the same, in a pulsatile or continuous manner.

Source: PVGPATDIS, file of 2026-04-10 (ipg120221.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Alkermes Pharma Ireland Limited 156 patentsForeign company or organizationDublin, IEPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
John DevaneAthlone, IE16PVGPATDIS, file of 2026-04-10
Paul StarkDundrum, IE1PVGPATDIS, file of 2026-04-10
Niall FanningDublin, IE1PVGPATDIS, file of 2026-04-10
Gurvinder Singh RekhiSuwanee, GA11PVGPATDIS, file of 2026-04-10
Scott JenkinsDowningtown, PA3PVGPATDIS, file of 2026-04-10
Gary LiversidgeWest Chester, PA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/5084PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P11/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-12-24Release of security interest
Release of patent security agreement (first lien)
MORGAN STANLEY SENIOR FUNDING, INC. signed 2024-12-19ALKERMES, INC. WALTHAM, MA
ALKERMES PHARMA IRELAND LIMITED DUBLIN 4
69771/548PASDL, file of 2026-10-15
2012-10-12Release of security interest
Release by secured party (second lien)
MORGAN STANLEY SENIOR FUNDING, INC. signed 2012-09-24ALKERMES, INC. WALTHAM, MA
ALKERMES PHARMA IRELAND LIMITED ATHLONE CO. WESTMEATH
ALKERMES CONTROLLED THERAPEUTICS INC. WALTHAM, MA
29116/379PASDL, file of 2026-10-15
2012-01-18Assignment
Assignment of assignor's interest
ELAN PHARMA INTERNATIONAL LIMITED signed 2011-08-02EDT PHARMA HOLDINGS LIMITED DUBLIN 227552/1ECORSEXC, file of 2026-09-25
2012-01-18Name change
Change of name
EDT PHARMA HOLDINGS LIMITED signed 2011-09-14ALKERMES PHARMA IRELAND LIMITED DUBLIN 227551/353ECORSEXC, file of 2026-09-25
2012-01-18Assignment
Assignment of assignor's interest
ELAN CORPORATION, PLC signed 2006-12-31ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH27551/107ECORSEXC, file of 2026-09-25
2012-01-18Assignment
Assignment of assignor's interest
DEVANE, JOHN G. signed 1999-10-29
STARK, PAUL signed 1999-10-29
ELAN CORPORATION, PLC DUBLIN 227550/921ECORSEXC, file of 2026-09-25
2012-01-17Assignment
Assignment of assignor's interest
FANNING, NIALL signed 2007-08-31ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH27543/320ECORSEXC, file of 2026-09-25
2012-01-17Assignment
Assignment of assignor's interest
JENKINS, SCOTT signed 2007-12-18
REKHI, GURVINDER signed 2007-12-18
LIVERSIDGE, GARY signed 2008-01-02
ELAN PHARMA INTERNATIONAL LIMITED COUNTY WESTMEATH27543/187ECORSEXC, file of 2026-09-25
2011-09-29Security interest Security interest
Patent security agreement (second lien)
ALKERMES, INC. signed 2011-09-16
ALKERMES PHARMA IRELAND LIMITED signed 2011-09-16
ALKERMES CONTROLLED THERAPEUTICS INC. signed 2011-09-16
MORGAN STANLEY SENIOR FUNDING, INC. NEW YORK, NY26994/245PASDL, file of 2026-10-15
2011-09-29Security interest Security interest
Patent security agreement (first lien)
ALKERMES, INC. signed 2011-09-16
ALKERMES PHARMA IRELAND LIMITED signed 2011-09-16
ALKERMES CONTROLLED THERAPEUTICS INC. signed 2011-09-16
MORGAN STANLEY SENIOR FUNDING, INC. NEW YORK, NY26994/186PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.